bioRxivNeuroscience
Reward learning deficits in Parkinson’s disease depend on depression
Monique HM Timmer, Guillaume SescousseiD, Marieke E van der Schaaf, Rianne AJ Esselink, Roshan CoolsiD
Abstract
BackgroundDepression is one of the most common and debilitating non-motor symptoms of Parkinsons disease (PD). The neurocognitive mechanisms underlying depression in PD are unclear and treatment is often suboptimal.\n\nMethodsWe investigated the role of striatal dopamine in reversal learning from reward and punishment by combining a controlled medication withdrawal procedure with functional magnetic resonance imaging (fMRI) in 22 non-depressed PD patients and 19 PD patients with past or present PD-related depression.\n\nResultsPD patients with a PD-related depression (history) exhibited impaired reward versus punishment reversal learning as well as reduced reward versus punishment-related BOLD signal in the striatum (putamen) compared with non-depressed PD patients. No effects of dopaminergic medication were observed.\n\nConclusionsThe present findings demonstrate that impairments in reversal learning from reward versus punishment and associated reward-related striatal signalling depend on the presence of (a history of) depression in PD.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Depression in Parkinson's disease is associated with dopamine unresponsive reduced reward sensitivity during effort-based decision making
Harry Costello, Yumeya Yamamori, … Jonathan Paul Roiser·bioRxiv·May 9, 2024
- Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson’s disease
Brónagh McCoy, Sara Jahfari, … Jan Theeuwes·BrainPeer-reviewed·Aug 31, 2019
- Two routes to value-based decisions in Parkinsons disease: differentiating incremental reinforcement learning from episodic memory
Leila Montaser‐Kouhsari, Jonathan Nicholas, … Daphna Shohamy A·bioRxiv·May 3, 2024
- Dopaminergic drugs decrease loss aversion in Parkinson’s disease with but not without depression
Monique H.M. Timmer, Guillaume Sescousse, … Roshan Cools·bioRxiv·Aug 11, 2016
- Attention and reinforcement learning in Parkinson's disease
Brónagh McCoy, Rebecca P Lawson, Jan Theeuwes·bioRxiv·Sep 12, 2020
- Dopamine modulates learning-related changes in dynamic striatal-cortical connectivity in Parkinson’s disease
Raphael T. Gerraty, Madeleine E. Sharp, … Daphna Shohamy A·bioRxiv·Apr 26, 2019